Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Biotech
Cabaletta’s CAR-T wipes out B cells with no preconditioning
Treatment with rese-cel depleted B cells in three patients with an autoimmune disease, sparking a complete B cell reset in two of them.
Darren Incorvaia
Oct 10, 2025 11:11am
BMS inks $1.5B deal to pull Orbital into its sphere of influence
Oct 10, 2025 8:45am
Shuttle Pharma launches into AI drug discovery via $10M buy
Oct 10, 2025 7:00am
Ono's BMS-partnered IO drug passes phase 2 gastric cancer test
Oct 9, 2025 10:10am
AviadoBio secures option to rare eye disease gene therapy
Oct 9, 2025 8:50am
Novo inks $4.7B Akero buyout to bag late-phase MASH prospect
Oct 9, 2025 8:21am